Major new fundraise positions MycoTechnology to take its mushroom mycelia platform onto the global stage

Jun 12, 2022

AURORA, Colo., March 31, 2022 /PRNewswire/ -- MycoTechnology, Inc., the world's leading explorer of mushroom mycelia, has set its sights on achieving global scale and realizing its innovation pipeline after securing a funding injection of $85 million. The recently concluded Series E fundraise represents the Colorado-based company's largest single round of financing since it was established in 2013, bringing total fundraising to-date to more than $200 million.

This new investment will allow MycoTechnology to further capitalize on its proprietary fermentation platform, continuing to impact food and nutrition around the world. The company is now positioned to bring its unique product portfolio to even more consumers globally, with a focus on expanding in Europe, Asia, and the Middle East.

The Series E round was led by a group affiliated with the Oman Investment Authority (OIA), a sovereign wealth fund and first-time investor in the business. Their sights are set on major collaborations around food security and sustainability. In addition to OIA, the Series E funding round attracted several new investors, including Nourish Ventures (Griffith Foods' venture capital group), Rage Capital, Alphacy Investment, and Siddhi Capital. Also contributing were returning investors S2G Ventures, Tyson Ventures, Continental Grain Company, Bunge Ventures, Maple Leaf Foods, Evolution VC Partners, and Gaingels.

Please read the full article here.

Source: CISION PR Newwire, news provided by MycoTechnology, Inc

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.